Tetrastatin binds integrin alphaVbeta3

Stable Identifier
R-HSA-4088218
Type
Reaction [binding]
Species
Homo sapiens
Compartment
plasma membrane, extracellular region
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Tetrastatin binds integrin alphaVbeta3
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Tetrastatin, the non-collagenous C-terminal domain of collagen alpha-4(IV) has anti-tumor activity in a human melanoma model, decreasing proliferative and invasive properties of melanoma cells. This effect is mediated by integrin alphaVBeta3.

Literature References
PubMed ID Title Journal Year
22539938 Tetrastatin, the NC1 domain of the ?4(IV) collagen chain: a novel potent anti-tumor matrikine

Brassart-Pasco, S, Sénéchal, K, Thevenard, J, Ramont, L, Devy, J, Di Stefano, L, Dupont-Deshorgue, A, Brézillon, S, Feru, J, Jazeron, JF, Diebold, MD, Ricard-Blum, S, Maquart, FX, Monboisse, JC

PLoS ONE 2012
Participants
Input
Output
Participant Of
hasEvent
Orthologous Events
Tetrastatin binds integrin alphaVbeta3 (Canis familiaris)
Tetrastatin binds integrin alphaVbeta3 (Mus musculus)
Tetrastatin binds integrin alphaVbeta3 (Rattus norvegicus)
Tetrastatin binds integrin alphaVbeta3 (Sus scrofa)
Authored
Jupe, S  (2012-08-08)
Reviewed
Ricard-Blum, S  (2013-08-13)
Created
Jupe, S  (2013-08-12)
Cite Us!